N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide

C20H25N3O3S — CID 41144802

IUPACN-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
SMILESC[C@@H]1CCCC[C@@]12NC(=O)N(CC(=O)N[C@@H]1CCSc3ccccc31)C2=O
InChIInChI=1S/C20H25N3O3S/c1-13-6-4-5-10-20(13)18(25)23(19(26)22-20)12-17(24)21-15-9-11-27-16-8-3-2-7-14(15)16/h2-3,7-8,13,15H,4-6,9-12H2,1H3,(H,21,24)(H,22,26)/t13-,15-,20-/m1/s1
InChIKeyJEDCPVROQNFRNF-WAWZGNHOSA-N
MW387.51 g/mol
LogP2.84
Rot. Bonds3

About N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide

N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide (PubChem CID 41144802) has the molecular formula C20H25N3O3S and a molecular weight of 387.51 g/mol. Its IUPAC name is N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide.

Molecular Properties

Compound NameN-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
PubChem CID41144802
Molecular FormulaC20H25N3O3S
Molecular Weight387.51 g/mol
Exact Mass387.16
IUPAC NameN-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide
SMILESC[C@@H]1CCCC[C@@]12NC(=O)N(CC(=O)N[C@@H]1CCSc3ccccc31)C2=O
InChIInChI=1S/C20H25N3O3S/c1-13-6-4-5-10-20(13)18(25)23(19(26)22-20)12-17(24)21-15-9-11-27-16-8-3-2-7-14(15)16/h2-3,7-8,13,15H,4-6,9-12H2,1H3,(H,21,24)(H,22,26)/t13-,15-,20-/m1/s1
InChIKeyJEDCPVROQNFRNF-WAWZGNHOSA-N
XLogP2.84
TPSA78.51 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500387.51
LogP ≤ 52.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The IUPAC name of N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide (CID 41144802) is N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide.
What is the SMILES notation for N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The canonical SMILES for N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide is C[C@@H]1CCCC[C@@]12NC(=O)N(CC(=O)N[C@@H]1CCSc3ccccc31)C2=O.
What is the InChIKey of N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
The InChIKey is JEDCPVROQNFRNF-WAWZGNHOSA-N. The full InChI is InChI=1S/C20H25N3O3S/c1-13-6-4-5-10-20(13)18(25)23(19(26)22-20)12-17(24)21-15-9-11-27-16-8-3-2-7-14(15)16/h2-3,7-8,13,15H,4-6,9-12H2,1H3,(H,21,24)(H,22,26)/t13-,15-,20-/m1/s1.
What are the key properties of N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide?
N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide has a molecular weight of 387.51 g/mol, XLogP of 2.84, 3 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-3,4-dihydro-2H-thiochromen-4-yl]-2-[(5R,6R)-6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetamide is sourced from PubChem (CID 41144802), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).